Atlas Trials

A Pilot Trial of Preoperative Irradiation With the STRIDE (Single Dose of Tremelimumab With Ongoing Durvalumab) Regimen (PRISM) for Resectable/Advanced Hepatocellular Carcinoma

Clinical trial NCT06994299 · WITHDRAWN

Trial details

NCT number
NCT06994299
Sponsor
Weill Medical College of Cornell University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Carcinoma (HCC)
Start date
2025-10-01
Primary completion
2027-07-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.